|
Index of reports
> Cases resulting in hospitalization (13)
> Cases with Disorientation (6)
Below is the selection of adverse event reports related to MS Contin (Morphine) that includes cases resulting in hospitalization where reactions include disorientation.
Adverse event in female receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-06-22
Patient: female
Adverse reactions / side effects: Abnormal Behaviour, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin (Morphine)
Adverse event in male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-06-22
Patient: male
Adverse reactions / side effects: Abnormal Behaviour, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin (Morphine)
Adverse event in male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-06-22
Patient: male
Adverse reactions / side effects: Abnormal Behaviour, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin
Dosage: unk mg, see text
Indication: Procedural Pain
Oxymorphone Hydrochloride
Dosage: unk, unk
Indication: Bone Pain
Adverse event in male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-06-22
Patient: male
Adverse reactions / side effects: Abnormal Behaviour, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin
Dosage: unk mg, see text
Indication: Procedural Pain
Oxymorphone Hydrochloride
Dosage: unk, unk
Indication: Bone Pain
Adverse event in 52 year old female receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-01-18
Patient: 52 year old female, weighing 63.0 kg (138.6 pounds)
Adverse reactions / side effects: Weight Decreased, Asthma, Abdominal Pain, Pyrexia, Loss of Consciousness, Pneumonia, Drug Abuser, Drug Withdrawal Syndrome, Delirium, Tremor, Paraesthesia, Dehydration, Anorexia, Disturbance in Attention, Vision Blurred, Pain, Disorientation, Somnolence, Speech Disorder, Myalgia, RED Blood Cell Count Decreased, Injection Site Reaction, Dizziness, Depression, Vomiting, Nausea, Dental Caries, Blood Potassium Decreased, Diarrhoea, Alopecia, Bronchitis, Memory Impairment, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin
Dosage: unk, unk
Indication: Drug USE FOR Unknown Indication
Start date: 2005-09-25
PEG-Intron
Dosage: unk, unk
Indication: Hepatitis C
Start date: 2005-09-25
Ribasphere
Dosage: unk, unk
Indication: Hepatitis C
Start date: 2005-09-25
Other drugs received by patient: Aspirin; Buspar; Calcium; Glucosamine W / Chondroitin Sulfates; Hydromorphone HCL; Lecithin; Levothyroxine Sodium; Vitamin CAP; Omega-3; Promethazine; Vitamin A+D; Vitamin B Complex CAP; Ascorbic Acid; Vitamin E; Wellbutrin; Albuterol Sulate; Flaxseed OIL; Inderal; Epogen; Iron
Adverse event in 52 year old female receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification from United States on 2007-01-16
Patient: 52 year old female, weighing 63.0 kg (138.6 pounds)
Adverse reactions / side effects: Weight Decreased, Abdominal Pain, Asthma, Pyrexia, Loss of Consciousness, Injection Site Erythema, Pneumonia, Drug Abuser, Injection Site Bruising, Drug Withdrawal Syndrome, Delirium, Tremor, Paraesthesia, Respiratory Tract Congestion, Anorexia, Dehydration, Vision Blurred, Disturbance in Attention, Pain, Injection Site Swelling, Disorientation, Somnolence, Speech Disorder, Myalgia, RED Blood Cell Count Decreased, Injection Site Reaction, Dizziness, Depression, Vomiting, Nausea, Dental Caries, Burning Sensation, Diarrhoea, Blood Potassium Decreased, Alopecia, Bronchitis, Memory Impairment, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: unk, unk
Indication: Hepatitis C
Start date: 2005-09-25
Ribasphere
Administration route: Oral
Indication: Hepatitis C
Start date: 2005-09-25
MS Contin
Dosage: unk, unk
Indication: Drug USE FOR Unknown Indication
End date: 2005-10-01
MS Contin
Start date: 2005-01-01
MS Contin
End date: 2005-09-25
Other drugs received by patient: Aspirin; Buspar; Calcium; Glucosamine W / Chondroitin Sulfates; Hydromorphone HCL; Inderal; Lecithin; Levothyroxine Sodium; Morphine Sulfate; Vitamin CAP; Omega-3; Promethazine; Vitamin A and D; Vitamin B Complex CAP; Ascorbic Acid; Vitamin E; Wellbutrin; Morphine Sulfate; Flaxseed OIL; Calcium; Albuterol; Epogen; Iron; Inderal; Doxycycline Hydrochloride
|
